CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
For the period ended Dec 27, 2025. Filed Feb 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 18, 2026
CRL$353.34+4.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | 60 |
|---|---|
| Consolidated Statements of Income (Loss) for fiscal years 2025, 2024 and 2023 | 63 |
| Consolidated Statements of Comprehensive Income (Loss) for fiscal years 2025, 2024 and 2023 | 64 |
| Consolidated Balance Sheets as of December 27, 2025 and December 28, 2024 | 65 |
| Consolidated Statements of Cash Flows for fiscal years 2025, 2024 and 2023 | 66 |
| Consolidated Statements of Changes in Equity and Redeemable Noncontrolling Interests for fiscal years 2025, 2024 and 2023 | 67 |
| Notes to Consolidated Financial Statements | 68 |
| Note 1. Description of Business and Summary of Significant Accounting Policies | 68 |
| Note 2. Acquisitions | 77 |
| Note 3. Revenue from Contracts with Customers | 79 |
| Note 4. Segment and Geographic Information | 80 |
| Note 5. Supplemental Cash Flow Information | 83 |
| Note 6. Inventory | 83 |
| Note 7. Property, Plant and Equipment, Net | 84 |
| Note 8. Venture Capital and Strategic Equity Investments | 84 |
| Note 9. Fair Value | 85 |
| Note 10. Goodwill and Intangible Assets | 87 |
| Note 11. Debt and Other Financing Arrangements | 89 |
| Note 12. Equity and Noncontrolling Interest | 91 |
| Note 13. Income Taxes | 94 |
| Note 14. Employee Benefit Plans | 98 |
| Note 15. Stock-based Compensation | 102 |
| Note 16. Restructuring and Asset Impairments | 104 |
| Note 17. Leases | 106 |
| Note 18. Commitments and Contingencies | 108 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.